Patents-Review.com
🔗 Permalink
Assignee profile:

InnoSIGN B.V.

City:

EINDHOVEN

Country:

Netherlands

Published Applications:

16

Last publication date:

2026-03-05

Patent Grants:

5

Last grant date:

2023-10-03

Top Inventors for applications by InnoSIGN B.V.

These are the the leading inventors for applications assigned to InnoSIGN B.V.:

Recent patent applications by InnoSIGN B.V.

InnoSIGN B.V. based in EINDHOVEN, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-03-05
US20260062755A1
Chemistry; metallurgy

PREDICTION AND MONITORING OF IMMUNOTHERAPY IN CANCER

 #2 | 2024-02-15
US20240052415A1
Chemistry; metallurgy

COMPARISON AND STANDARDIZATION OF CELL AND TISSUE CULTURE

 #3 | 2024-02-08
US20240043930A1
Chemistry; metallurgy

TREATMENT PREDICTION AND EFFECTIVENESS OF ANTI-TNF ALPHA TREATMENT IN IBD PATIENTS

 #4 | 2023-12-28
US20230416820A1
Chemistry; metallurgy

PCR METHOD AND KIT FOR DETERMINING PATHWAY ACTIVITY

 #5 | 2023-11-09
US20230357862A1
Chemistry; metallurgy

METHOD FOR PREDICTING IMMUNOTHERAPY RESISTANCE

 #6 | 2023-08-17
US20230260595A1
Physics

DETERMINATION OF NFKB PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES

 #7 | 2023-07-13
US20230223108A1
Physics

PROGNOSTIC PATHWAYS FOR VIRAL INFECTIONS

 #8 | 2023-04-06
US20230105263A1
Physics

ASSESSMENT OF CELLULAR SIGNALING PATHWAY ACTIVITY USING PROBABILISTIC MODELING OF TARGET GENE EXPRESSION

 #9 | 2023-03-30
US20230098637A1
Chemistry; metallurgy

PROGNOSTIC PATHWAYS FOR HIGH RISK SEPSIS PATIENTS

 #10 | 2023-03-09
US20230071390A1
Chemistry; metallurgy

ASSESSMENT OF PR CELLULAR SIGNALING PATHWAY ACTIVITY USING MATHEMATICAL MODELLING OF TARGET GENE EXPRESSION

 #11 | 2023-02-02
US20230030858A1
Chemistry; metallurgy

ASSESSMENT OF CELLULAR SIGNALING PATHWAY ACTIVITY USING LINEAR COMBINATION(S) OF TARGET GENE EXPRESSIONS

 #12 | 2019-06-20 ✅ Patent 11,776,661 granted on 2023-10-03
US20190188359A1
Physics

Determination of MAPK-AP-1 pathway activity using unique combination of target genes

 #13 | 2019-04-04 ✅ Patent 12,125,561 granted on 2024-10-22
US20190102510A1
Physics

Determination of JAK-STAT3 pathway activity using unique combination of target genes

 #14 | 2019-04-04 ✅ Patent 11,649,488 granted on 2023-05-16
US20190100795A1
Chemistry; metallurgy

Determination of JAK-STAT1/2 pathway activity using unique combination of target genes

 #15 | 2017-02-16 ✅ Patent 11,450,409 granted on 2022-09-20
US20170046477A1
Physics

Determination of NFkB pathway activity using unique combination of target genes

 #16 | 2014-06-05 ✅ Patent 11,443,831 granted on 2022-09-13
US20140156200A1
Physics

Assessment of cellular signaling pathway activity using probabilistic modeling of target gene expression

Also check out InnoSIGN B.V.'s (Eindhoven, Netherlands) applicant profile with 5 patent applications submitted.

AssigneeID:

333411 ⎘